Myocardial Dysfunction and Shock after Cardiac Arrest.
Jentzer JC, Chonde MD, Dezfulian C.
Biomed Res Int. 2015;2015:314796. doi: 10.1155/2015/314796. Epub 2015 Sep 2.
Myocardial dysfunction in sepsis.
Piper RD.
Clin Exp Pharmacol Physiol. 1998 Nov;25(11):951-4. doi: 10.1111/j.1440-1681.1998.tb02351.x.
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
Jia G, Hill MA, Sowers JR.
Circ Res. 2018 Feb 16;122(4):624-638. doi: 10.1161/CIRCRESAHA.117.311586.
Myocardial fibrosis, the silent instigator of diastolic dysfunction in patients with rheumatoid arthritis.
Jalali M, Števlík J, Jalali Y, Gažová A, Kyselovič J, Killinger Z, Payer J.
Physiol Res. 2025 Jul 23;74(3):347-358.
Postresuscitation myocardial dysfunction after asphyxial cardiac arrest: is it time to reconsider the existing paradigm?
Xanthos T, Chalkias A.
Am J Emerg Med. 2013 Dec;31(12):1697-8. doi: 10.1016/j.ajem.2013.08.060. Epub 2013 Oct 1.
Exosomes and non-coding RNAs: Exploring their roles in human myocardial dysfunction.
Kulus M, Farzaneh M, Sheykhi-Sabzehpoush M, Ghaedrahmati F, Mehravar F, Józkowiak M, Piotrowska-Kempisty H, Bukowska D, Antosik P, Podhorska-Okołów M, Zabel M, Mozdziak P, Dzięgiel P, Kempisty B.
Biomed Pharmacother. 2025 Feb;183:117853. doi: 10.1016/j.biopha.2025.117853. Epub 2025 Jan 18.
Myocardial viability.
Birnbaum Y, Kloner RA.
West J Med. 1996 Dec;165(6):364-71.
Neutrophil Extracellular Traps in Myocardial Tissue Drive Cardiac Dysfunction and Adverse Outcomes in Patients With Heart Failure With Dilated Cardiomyopathy.
Ichimura S, Misaka T, Ogawara R, Tomita Y, Anzai F, Sato Y, Miura S, Yokokawa T, Sato T, Oikawa M, Kobayashi A, Yoshihisa A, Takeishi Y.
Circ Heart Fail. 2024 Jun;17(6):e011057. doi: 10.1161/CIRCHEARTFAILURE.123.011057. Epub 2024 Jun 7.
Inflammatory mediators and reversible myocardial dysfunction.
Kan H, Finkel MS.
J Cell Physiol. 2003 Apr;195(1):1-11. doi: 10.1002/jcp.10213.
Myocardial ischemia.
Nakamura M.
Jpn Circ J. 1985 Jan;49(1):1-12. doi: 10.1253/jcj.49.1.
